The Genetic Disorders Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.
Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milestone and royalty rate payments
Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by most active dealmakers, top deals by value, big pharma and big biotech activity, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
Table of Content
Chapter 1 – Trends in dealmaking during 2014
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area
Chapter 2 – Average financial deal terms
2.1 Partnering deals with headline values
2.2 Partnering deals with upfront payments
2.3 Partnering deals with milestone payments
2.4 Partnering deals withroyalty rates
Chapter 3 – Leading deals during 2014
3.2. Most active dealmakers
3.3. Top deals by value during 2014
3.4. Big pharma dealmaking activity
3.5. Big biotech dealmaking activity
Chapter 4 – Partnering deals directory 2014
4.2. Company A-Z
4.3. By deal type
4.4. By stage of development
4.5. By technology type
4.6. By therapy area
About Wildwood Ventures
List of Chart
Figure 1: Partnering by deal type during 2014
Figure 2: Partnering by industry sector during 2014
Figure 3: Partnering by stage of development during 2014
Figure 4: Partnering by technology type during 2014
Figure 5: Partnering by therapy area during 2014
Figure 6: Deals with a headline value
Figure 7: Deals with headline value distribution, US$million
Figure 8 Deals with upfront payment values
Figure 9: Deal with upfront payment distribution, US$million
Figure 10: Deals with milestone payments
Figure 11: Deals with royalty rates, %
Figure 12: Active dealmakers in 2014
Figure 13: Top deals by value during 2014
Figure 14: Big pharma – top 50 – January to December 2014
Figure 15: Big pharma deal frequency – 2014
Figure 16: Big biotech – top 50 – January to December 2014
Figure 17: Big biotech deal frequency – 2014
Make an enquiry before buying this Report
Please fill the enquiry form below.